CLINICSINTERVIEWPSYCH STOCK NEWS Interview: Matt Stang, CEO of Delic (DELCF). Wall Street Reporter By Editor | Curator - February 26, 2021 Facebook Twitter WhatsApp Linkedin ReddIt Email #delcf, #DELIC $delcf RELATED ARTICLESMORE FROM AUTHOR Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX. Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. (Ketamine.) Ketamine and Yale University Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research
